The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

The president's most favored nation drug pricing could also be problematic for Lilly, but perhaps not as much as feared. Eli Lilly's (NYSE: LLY) share price soared during the first Trump ...

Stocks were boosted in May by easing trade tensions, solid corporate earnings and signs the U.S. economy remains resilient ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

The Trump administration's escalating calls for drug companies to lower prices underscore just how stuck the industry is in ...

The deal prepares for a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from ...

They worry tariffs, aimed at bringing drug production to the United States, could instead drive companies out of business ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

Swiss President Karin Keller-Sutter will visit pharma powerhouse Ireland tomorrow for high-level talks ahead of President ...